This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: National Research Council of Canada. Active years: 2023.
Company Filing History:
Years Active: 2023
Title: Aziza Manceur: Innovator in Hemagglutinin-Specific Antibodies
Introduction
Aziza Manceur is a notable inventor based in Montreal, Canada. She has made significant contributions to the field of immunology, particularly in the development of antibodies that target hemagglutinin, a key protein found in various influenza strains. Her work is crucial in advancing our understanding and treatment of influenza viruses.
Latest Patents
Aziza Manceur holds a patent for "Hemagglutinin-specific antibodies and uses thereof." This invention relates to antibodies and their fragments that can recognize antigens from multiple influenza strains. The implications of this patent are significant, as it opens avenues for better diagnostic and therapeutic strategies against influenza.
Career Highlights
Manceur is affiliated with the National Research Council of Canada, where she conducts her research. Her work has been instrumental in the development of innovative solutions to combat influenza, showcasing her dedication to public health and scientific advancement.
Collaborations
Throughout her career, Aziza has collaborated with esteemed colleagues, including Anne Marcil and Amine A Kamen. These partnerships have enriched her research and contributed to the success of her projects.
Conclusion
Aziza Manceur is a pioneering inventor whose work on hemagglutinin-specific antibodies has the potential to transform influenza treatment. Her contributions to science and collaboration with other researchers highlight her commitment to innovation in the field of immunology.